Clinical Study of Virtual Reality Augmented Technology Combined with Contrast-Enhanced Ultrasound in the Assessment of Thyroid Cancer

Abstract

Thyroid cancer has become the most common malignant tumor in the endocrine system, and its global incidence has been showing an upward trend. The diagnosis methods of thyroid cancer include ultrasound, fine-needle aspiration cytology, and neck CT, but the single ultrasound feature cannot simultaneously take into account the sensitivity and specificity of more than 85% when diagnosing thyroid cancer. The development of virtual technology can significantly improve the diagnosis of the thyroid gland. Based on this, this article proposes a clinical study of virtual reality technology combined with contrast-enhanced ultrasound in the assessment of thyroid cancer. This article uses a variety of methods, such as literature method, mathematical statistics, and experimental research, in-depth study of the theoretical cornerstones of virtual reality augmented technology, the application status of ultrasound contrast technology, and so on. And a fuzzy mean clustering algorithm was proposed to identify ultrasound images. Then, a clinical experiment of virtual reality augmented technology combined with contrast-enhanced ultrasound was designed to evaluate thyroid cancer, which included comparison of contrast-enhanced ultrasound signs, analysis of enhancement results, multifactor logistic analysis, and diagnostic efficacy analysis of ultrasound signs. The combined application of virtual reality augmented technology and contrast-enhanced ultrasound in the study of thyroid cancer has a sensitivity and specificity exceeding 85% as the diagnosis boundary changes, and the accuracy of the combined diagnosis is relatively high.

Comparison of the effects of contrast-enhanced ultrasound and conventional ultrasound-guided radiofrequency ablation on benign thyroid nodules

“…It’s possible that CEUS allows for an increased visualization of the thyroid nodule which improves the accuracy of the ablation and further improves the safety of ablation treatment, and reduces the occurrence of complications. 24 , 25 Based on the above analysis, when treating BTNs clinically, we suggest that those who meet the following conditions can actively choose CEUS-guided RFA to further improve the clinical benefits of patients: Patients whose nodules are benign, who have no prior history of radiation therapy, who have autonomic functional nodules, hyperthyroidism symptoms, or conscious symptoms. At the same time, attention should be paid to the elimination of contraindications of RFA treatment which are as below: Patients with huge retrosternal goiter, or nodules located retrosternal, vocal cord insufficiency contralateral to the lesion, coagulation impairment, or organ insufficiency.…”

Retracted: Clinical Study of Virtual Reality Augmented Technology Combined with Contrast‐Enhanced Ultrasound in the Assessment of Thyroid Cancer

“…Tis article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. Tis investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process:…”

“…This article has been retracted by Hindawi following an investigation undertaken by the publisher [ 1 ]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: Discrepancies in scope Discrepancies in the description of the research reported Discrepancies between the availability of data and the research described Inappropriate citations Incoherent, meaningless and/or irrelevant content included in the article Peer-review manipulation …”